Literature DB >> 8849824

Reproducibility and observer variability of transrectal ultrasound measurements of prostatic volume.

G N Collins1, G M Raab, M Hehir, B King, W M Garraway.   

Abstract

Transrectal ultrasound (TRUS) is an established investigation in benign and malignant prostatic disease though the level of reproducibility of TRUS volume measurements is not known. A group of observers in the UK and the USA who were participating in linked prospective studies of benign prostatic hyperplasia each carried out measurements during real-time scanning and on a series of static TRUS images. Results demonstrated good reproducibility for measurements of antero-posterior, transverse, and longitudinal dimensions of the prostate by an experienced UK urologist; only a minor degree of interobserver variation occurred in measurements made between experienced UK and USA observers. Using static images, USA observers obtained results that were in good agreement, whereas the UK observers, only two of whom used TRUS regularly, were in poor agreement with each other. This study demonstrates a high level of reproducibility for TRUS volume measurements performed by experienced observers.

Entities:  

Mesh:

Year:  1995        PMID: 8849824     DOI: 10.1016/0301-5629(95)02001-2

Source DB:  PubMed          Journal:  Ultrasound Med Biol        ISSN: 0301-5629            Impact factor:   2.998


  8 in total

1.  Lower urinary tract symptoms (LUTS) in males with type 2 diabetes recently treated with SGLT2 inhibitors-overlooked and overwhelming? A retrospective case series.

Authors:  Nino Cristiano Chilelli; Giuseppe Bax; Giulio Bonaldo; Eugenio Ragazzi; Massimo Iafrate; Filiberto Zattoni; Federico Bellavere; Annunziata Lapolla
Journal:  Endocrine       Date:  2017-04-18       Impact factor: 3.633

2.  [Parameters to improve the specificity of the prostate-specific antigen. Early detection of prostate cancer].

Authors:  C Börgermann; S Kliner; A Swoboda; H-J Luboldt; H Rübben
Journal:  Urologe A       Date:  2011-09       Impact factor: 0.639

3.  Novel ultrasound-based volume estimation of prostatic benign enlargement to improve decision-making on surgical approach.

Authors:  Snir Dekalo; Ziv Savin; Eran Schreter; Ron Marom; Yuval Bar-Yosef; Roy Mano; Ofer Yossepowitch; Mario Sofer
Journal:  Ther Adv Urol       Date:  2021-02-11

4.  Reliability and validity of assessment methods available in primary care for bladder outlet obstruction and benign prostatic obstruction in men with lower urinary tract symptoms: a systematic review.

Authors:  Tom Vredeveld; Esther van Benten; Rikie E P M Beekmans; M Patrick Koops; Johannes C F Ket; Jurgen Mollema; Stephan P J Ramaekers; Jan J M Pool; Michel W Coppieters; Annelies L Pool-Goudzwaard
Journal:  BMJ Open       Date:  2022-04-29       Impact factor: 3.006

5.  The European Academy of Andrology (EAA) ultrasound study on healthy, fertile men: Prostate-vesicular transrectal ultrasound reference ranges and associations with clinical, seminal and biochemical characteristics.

Authors:  Francesco Lotti; Francesca Frizza; Giancarlo Balercia; Arcangelo Barbonetti; Hermann M Behre; Aldo E Calogero; Jann-Frederik Cremers; Felice Francavilla; Andrea M Isidori; Sabine Kliesch; Sandro La Vignera; Andrea Lenzi; Marios Marcou; Adrian Pilatz; Olev Poolamets; Margus Punab; Maria Fernanda Peraza Godoy; Claudia Quintian; Osvaldo Rajmil; Gianmaria Salvio; Osama Shaeer; Wolfgang Weidner; Elisa Maseroli; Sarah Cipriani; Elisabetta Baldi; Selene Degl'Innocenti; Giovanna Danza; Anna Lucia Caldini; Alessandro Terreni; Luca Boni; Csilla Krausz; Mario Maggi
Journal:  Andrology       Date:  2022-07-19       Impact factor: 4.456

6.  Correlations between the various methods of estimating prostate volume: transabdominal, transrectal, and three-dimensional US.

Authors:  Sun Ho Kim; Seung Hyup Kim
Journal:  Korean J Radiol       Date:  2008 Mar-Apr       Impact factor: 3.500

7.  Metabolic syndrome and prostate abnormalities in male subjects of infertile couples.

Authors:  Francesco Lotti; Giovanni Corona; Linda Vignozzi; Matteo Rossi; Elisa Maseroli; Sarah Cipriani; Mauro Gacci; Gianni Forti; Mario Maggi
Journal:  Asian J Androl       Date:  2014 Mar-Apr       Impact factor: 3.285

8.  Three-year outcome analysis of alpha 1-blocker naftopidil for patients with benign prostatic hyperplasia in a prospective multicenter study in Japan.

Authors:  Naoya Masumori; Taiji Tsukamoto; Akihiko Shibuya; Noriomi Miyao; Yasuharu Kunishima; Akihiko Iwasawa
Journal:  Patient Prefer Adherence       Date:  2016-07-22       Impact factor: 2.711

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.